ArticleFrontiers in pharmacology2025

Cost-effectiveness analysis of sintilimab additional to chemoradiotherapy in high-risk locoregionally advanced nasopharyngeal carcinoma.

Longjiang She et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.